TalkMed Group Limited's (SGX:5G3) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?




  • In Business
  • 2022-11-28 23:52:15Z
  • By Simply Wall St.
 

TalkMed Group (SGX:5G3) has had a rough week with its share price down 2.5%. But if you pay close attention, you might find that its key financial indicators look quite decent, which could mean that the stock could potentially rise in the long-term given how markets usually reward more resilient long-term fundamentals. Specifically, we decided to study TalkMed Group's ROE in this article.

Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.

Check out our latest analysis for TalkMed Group

How Is ROE Calculated?

ROE can be calculated by using the formula:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for TalkMed Group is:

27% = S$23m ÷ S$87m (Based on the trailing twelve months to June 2022).

The 'return' is the amount earned after tax over the last twelve months. So, this means that for every SGD1 of its shareholder's investments, the company generates a profit of SGD0.27.

What Has ROE Got To Do With Earnings Growth?

So far, we've learned that ROE is a measure of a company's profitability. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company's earnings growth potential. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics.

TalkMed Group's Earnings Growth And 27% ROE

Firstly, we acknowledge that TalkMed Group has a significantly high ROE. Second, a comparison with the average ROE reported by the industry of 11% also doesn't go unnoticed by us. For this reason, TalkMed Group's five year net income decline of 6.0% raises the question as to why the high ROE didn't translate into earnings growth. We reckon that there could be some other factors at play here that are preventing the company's growth. Such as, the company pays out a huge portion of its earnings as dividends, or is faced with competitive pressures.

So, as a next step, we compared TalkMed Group's performance against the industry and were disappointed to discover that while the company has been shrinking its earnings, the industry has been growing its earnings at a rate of 9.4% in the same period.

Earnings growth is an important metric to consider when valuing a stock. It's important for an investor to know whether the market has priced in the company's expected earnings growth (or decline). By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. One good indicator of expected earnings growth is the P/E ratio which determines the price the market is willing to pay for a stock based on its earnings prospects. So, you may want to check if TalkMed Group is trading on a high P/E or a low P/E, relative to its industry.

Is TalkMed Group Efficiently Re-investing Its Profits?

TalkMed Group has a high three-year median payout ratio of 89% (that is, it is retaining 11% of its profits). This suggests that the company is paying most of its profits as dividends to its shareholders. This goes some way in explaining why its earnings have been shrinking. The business is only left with a small pool of capital to reinvest - A vicious cycle that doesn't benefit the company in the long-run. You can see the 3 risks we have identified for TalkMed Group by visiting our risks dashboard for free on our platform here.

In addition, TalkMed Group has been paying dividends over a period of nine years suggesting that keeping up dividend payments is preferred by the management even though earnings have been in decline.

Conclusion

In total, it does look like TalkMed Group has some positive aspects to its business. Although, we are disappointed to see a lack of growth in earnings even in spite of a high ROE. Bear in mind, the company reinvests a small portion of its profits, which means that investors aren't reaping the benefits of the high rate of return. Up till now, we've only made a short study of the company's growth data. To gain further insights into TalkMed Group's past profit growth, check out this visualization of past earnings, revenue and cash flows.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You'll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here

COMMENTS

More Related News

AltynGold plc (LON:ALTN) Held Back By Insufficient Growth Even After Shares Climb 85%
AltynGold plc (LON:ALTN) Held Back By Insufficient Growth Even After Shares Climb 85%

Despite an already strong run, AltynGold plc ( LON:ALTN ) shares have been powering on, with a gain of 85% in the last...

Could The Market Be Wrong About CPT Global Limited (ASX:CGO) Given Its Attractive Financial Prospects?
Could The Market Be Wrong About CPT Global Limited (ASX:CGO) Given Its Attractive Financial Prospects?

It is hard to get excited after looking at CPT Global's (ASX:CGO) recent performance, when its stock has declined 9.9...

Does The Market Have A Low Tolerance For Compumedics Limited
Does The Market Have A Low Tolerance For Compumedics Limited's (ASX:CMP) Mixed Fundamentals?

Compumedics (ASX:CMP) has had a rough three months with its share price down 20%. We, however decided to study the...

Do Its Financials Have Any Role To Play In Driving Greenyield Berhad
Do Its Financials Have Any Role To Play In Driving Greenyield Berhad's (KLSE:GREENYB) Stock Up Recently?

Greenyield Berhad's (KLSE:GREENYB) stock is up by a considerable 5.0% over the past week. We wonder if and what role...

Investors Aren
Investors Aren't Buying Sylvamo Corporation's (NYSE:SLVM) Earnings

With a price-to-earnings (or "P/E") ratio of 5.4x Sylvamo Corporation ( NYSE:SLVM ) may be sending very bullish signals...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

  • kserietv
    (2022-11-29 05:56:29Z)

    As a seller of legal steroids, you can buy Crazy Bulk products, explore stacks and finally get the body you’ve always wanted

    REPLY
  • Slutty Vegan Brooklyn
    (2022-11-29 08:19:05Z)

    Beaver says I also have such interest, you can read my profile here:

    REPLY
  • wetv
    (2022-12-01 09:32:17Z)


    Easily, the article is actually the best topic on this registry related issue.

    REPLY
  • Anime izle
    (2022-12-05 10:46:02Z)

    This is what commonly happens to the newbies in the business industry who do not know how to effectively market their product or service or service.

    REPLY
  • Seriale Turcesti
    (2022-12-08 05:47:22Z)

    That is the clarification I can without a truly striking stretch picked power the making style and thought

    REPLY
  • Seriale online
    (2022-12-15 07:06:12Z)


    Thanks for picking out the time to discuss this, I feel great about it and love studying more on this topic. It is extremely helpful for me. Thanks for such a valuable help again.

    REPLY
  • filmefast
    (2022-12-17 05:47:39Z)

    Thanks for sharing nice information with us. i like your post and all you share with us is uptodate and quite informative, i would like to bookmark the page so i can come here again to read you, as you have done a wonderful job.

    REPLY
  • Buy Sandals Near Me
    (2023-01-05 06:21:16Z)

    I really thank you for the valuable info on this great subject and look forward to more great posts

    REPLY
  • Personally I think overjoyed I discovered the blogs.

    REPLY
  • สล็อตpg
    (2023-01-13 09:37:39Z)

    Very nice article. I enjoyed reading your post. very nice share. I want to twit this to my followers. Thanks !.

    REPLY
  • 9anime
    (2023-01-16 05:54:59Z)

    I genuinely enjoy your website, but I’m having a problem: any time I load one of your post in Firefox, the center of the web page is screwed up — which is bizarre. May I send you a screenshot? In any event, keep up the superior work; I definitely like reading you.

    REPLY
  • anime
    (2023-01-17 07:36:13Z)

    I on a focal level need to uncover to you that I am new to weblog and totally preferred this blog page. Conceivable I'm going to bookmark your blog . You everything considered have striking stories. Pulls for changing with us your blog.

    REPLY
  • topnovelas
    (2023-01-18 05:46:32Z)

    Hello! I just would like to give a huge thumbs up for the great info you have here on this post. I will be coming back to your blog for more soon.

    REPLY
  • I was exploring this particular info for a long time. Thanks to this blog my exploration has ended.

    REPLY
  • ver novelas
    (2023-01-21 11:54:09Z)

    I’m happy to find so many useful info here in the post, thanks for sharing. I’ll bookmark your blog and take the feeds also!

    REPLY
  • gem tv serial
    (2023-01-25 06:21:20Z)

    Excellent post. I was always checking this blog, and I’m impressed! Extremely useful info specially the last part, I care for such information a lot.

    REPLY
  • T-shirt printing
    (2023-01-25 06:48:25Z)

    Great Article it its really informative and innovative keep us posted with new updates. its was really valuable. thanks a lot.

    REPLY
  • dramacool
    (2023-01-26 06:37:04Z)

    After study many of the blogs on the website now, and i genuinely as if your strategy for blogging. I bookmarked it to my bookmark site list and you will be checking back soon. Pls take a look at my internet site as well and tell me if you agree.

    REPLY
  • kseries
    (2023-01-27 10:10:08Z)

    After study many of the blogs on the website now, and i genuinely as if your strategy for blogging. I bookmarked it to my bookmark site list and you will be checking back soon. Pls take a look at my internet site as well and tell me if you agree.

    REPLY

Top News: Business